{"acquisitions":[],"changes":[],"country":"US","description":"SBIR PHASE II: ANTIBODY-DRUG CONJUGATES (ADCS) WITH HIGH DRUG-ANTIBODY RATIOS (DAR) AND MOLECULARLY TARGETED PAYLOADS -T","domain":"indow.ai","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":38.393069,"lng":-76.099568,"location":"Dorchester, USA","multiples":[],"name":"Window Therapeutics, INC.","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":1000000,"connectionsAmong":[],"currency":"USD","date":"2025-01-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"indow-ai-2025-01-01-strategic","source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"strategic","url":null}],"slug":"indow-ai","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"indow.ai","retrievedAt":"2026-05-07","status":"self-reported","url":"https://indow.ai"},{"fact":"description","publisher":"indow.ai","retrievedAt":"2026-05-07","status":"self-reported","url":"https://indow.ai"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":[],"totalRaisedUsd":1000000,"traction":[],"updatedAt":"2026-05-07","valuations":[]}